Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
Glycosaminoglycan isolated from urine of a patient with the Hurler-Scheie compound syndrome consisted of dermatan sulfate (60%), heparan sulfate (34%) and chondroitin sulfate (6%). About 60% of both dermatan and chondroitin sulfates had molecular weight 8,000-10,000, while 95% of the heparan sulfate had molecular weight less than 6,000. The total sulfate content of the glycosaminoglycans increased with decrease in molecular weight. N-sulfate content in the heparan sulfate, however, had no relation to molecular weight, and was 0.33 mole per mole of glucosamine on the average. About 70% of the heparan sulfate with the lowest molecular weight (1,500) were composed of three repeating disaccharide units of heparan sulfate and two acetyl, one N-sulfate and three O-sulfate groups linked to the units. The dermatan sulfate contained 1.0-1.2 moles of sulfate per mole of galactosamine. Of the excess sulfate 45-65% were bound to iduronate residues and the rest to C-6 of N-acetylgalactosamine 4-sulfate residues. Most of the dermatan sulfate (83.2-100%) had nonsulfated iduronic acid at the non-reducing end. This finding is consistent with the defect of iduronidase in this disease.
D003871:Dermatan Sulfate / Q000032:analysis; D006025:Glycosaminoglycans / Q000652:urine*; D006497:Heparan Sulfate / Q000032:analysis; D006801:Humans; D008970:Molecular Weight; D008059:Mucopolysaccharidosis I / Q000652:urine*
D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate